We are an Oxford, UK-based business with a revolutionary computer-based platform and a unique network-driven drug discovery ("NDD") methodology which allows us to discover novel and better drugs faster.

Who we are
Process overview.jpg
What we do

Read more about our cutting edge in silico techniques, the importance of network science, our strategy and our assets.

What we do
News and Media

View our regulatory announcements, read our publications, see our videos and subscribe to receive email alerts.

News & media
Amazon_450x450.png (1)

We are a UK-based company listed (ETX.L) on the Alternative Investment Market (AIM), London Stock Exchange's international market for smaller, growing companies.


Share price


Share price information

Latest news

Expansion into RNAi and creation of SAB

Non Regulatory Announcement

Latest Regulatory Announcements

Partnering & Collaboration

Our NDD approach consistently generates potent and novel hits, assisting companies increase the productivity of their drug discovery.

Please get in touch at bd@etherapeutics.co.uk.